Embolic Protection Devices Market

Embolic Protection Devices Market (Product: Distal Occlusion Devices, Proximal Occlusion Devices, and Distal Filters) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Embolic Protection Devices Market Outlook 2031

  • The global industry was valued at US$ 564.5 Mn in 2022
  • It is projected to grow at a CAGR of 8.0% from 2023 to 2031 and reach more than US$ 1.1 Bn by 2031

Analysts’ Viewpoint

Increase in incidence of cardiovascular & neurovascular diseases across the world and rise in demand for minimally invasive procedures are the major factors driving the global embolic protection devices market. Embolic protection devices are useful in reducing the risk of complications during interventional procedures including angioplasty. Educational initiatives, training programs, and conferences focused on interventional cardiology and neurology have helped disseminate knowledge about the importance of embolic protection devices in preventing complications and improving patient outcomes.

Technological advancements in embolic protection devices have significantly improved their efficacy and safety profiles. Leading manufacturers in the embolic protection devices industry are developing safe, efficient, and innovative devices as well as next-generation devices with enhanced features, such as improved retrieval systems, better filter designs, and advanced imaging capabilities.

Embolic Protection Devices Market

Global Embolic Protection Devices Market Introduction

Embolic protection device (EPD) has emerged as a significant advancement in interventional cardiology and vascular procedures. Embolic protection devices are specifically designed to minimize the risk of embolization, a condition where debris or clots break loose from a treatment site and travel through the bloodstream, potentially causing blockages and complications in vital organs.

Introduction of embolic protection devices has revolutionized the field of cardiovascular interventions, particularly in complex procedures such as carotid artery stenting and transcatheter aortic valve replacement (TAVR).

These procedures involve the manipulation of diseased vessels and carry a risk of dislodging plaque or debris, leading to embolic events. EPDs provide a valuable solution by capturing and containing these embolic materials, thereby reducing the risk of embolization and related complications.

EPDs typically consist of a filter-based system that is deployed distal to the treatment site. These filters act as a mechanical barrier, catching embolic debris while allowing the passage of blood. After the intervention is completed, the EPD is retrieved, ensuring the captured material is safely removed from the patient's circulation.

Advancements in technology have made embolic protection devices more efficient and user-friendly. Newer devices offer enhanced capture capabilities, ensuring a higher success rate in capturing embolic debris. Moreover, rise in awareness among healthcare professionals about the importance of embolic protection is contributing to the increased demand for these devices.

Rise in Incidence of Cardiovascular & Neurovascular Diseases

Cardiovascular & neurovascular diseases are the leading causes of disability and mortality across the globe. Factors such as sedentary lifestyles, poor dietary habits, smoking, and aging population have contributed to rise in prevalence of these conditions. Hence, there is a growing need for advanced medical devices and treatments to address these health issues.

Embolic protection devices are designed to prevent emboli, which are blood clots or other foreign bodies, from traveling to critical organs such as the heart or brain during certain medical procedures. Embolic protection devices act as a barrier, capturing and removing these particles before they can cause damage or block blood flow in vital arteries.

Demand for embolic protection devices is rising due to increase in number of cardiovascular & neurovascular interventions, such as stenting and angioplasty. These procedures carry a risk of dislodging plaque or thrombi, leading to potential stroke or heart attack. By using embolic protection devices, physicians can minimize the risk of such complications, improving patient outcomes.

As technology continues to evolve, embolic protection devices are expected to play an increasingly vital role in cardiovascular interventions, offering enhanced safety, expanded treatment options, and improved patient outcomes.

Increase in Demand for Minimally Invasive Procedures Fueling Embolic Protection Devices Market Development

Minimally invasive procedures offer several advantages over traditional open surgeries, including smaller incisions, reduced pain & scarring, shorter hospital stay, and faster recovery. Hence, more patients and healthcare providers are opting for these procedures across various medical specialties.

People are increasingly seeking alternatives to invasive surgeries that require large incisions and longer recovery period. Minimally invasive procedures offer them the opportunity to undergo treatments with fewer complications, minimal disruption to their daily lives, and quicker return to normal activities. This has fueled the adoption of minimally invasive procedures, which, in turn, is propelling demand for embolic protection devices.

Embolic protection devices play a crucial role in ensuring the safety and effectiveness of minimally invasive procedures. These devices are used during interventions such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and endovascular aneurysm repair (EVAR), where the risk of embolic events is higher.

By using embolic protection devices, physicians can minimize the risk of emboli dislodgment and subsequent complications, making these procedures safer and more successful. Hence, demand for embolic protection devices is rising significantly with the increase in adoption of minimally invasive procedures.

Manufacturers are developing more advanced and efficient embolic protection devices to meet the growing market needs. Technological advancements are expected to propel the embolic protection devices market progress during the forecast period.

Surge in Demand for Distal Filters Augmenting Market Statistics

In terms of product, the distal filters segment accounted for the largest global embolic protection devices market share in 2022. This segment is projected to lead the global market during the forecast period.

Distal filters have been widely adopted in various interventional procedures, including percutaneous coronary intervention (PCI) and carotid artery stenting. These devices are designed to capture and prevent embolic debris from reaching distal vessels, thereby reducing the risk of complications such as stroke or organ damage.

High prevalence of cardiovascular diseases, particularly coronary artery disease and carotid artery stenosis, has led to substantial demand for distal filter devices in these specific procedures. Product innovations have further propelled the growth of this segment.

Rise in Demand for Embolic Protection Devices in Cardiovascular Procedures

Based on indication, the cardiovascular diseases segment dominated the global market in 2022. Cardiovascular diseases, including coronary artery disease and peripheral artery disease, are among the leading causes of morbidity and mortality worldwide. These conditions often require interventional procedures such as percutaneous coronary intervention (PCI) and angioplasty to restore blood flow to the affected vessels.

During these procedures, embolic protection devices play a crucial role in preventing the release of embolic debris, such as blood clots or plaque fragments, into the bloodstream. By capturing and removing these emboli, these devices help reduce the risk of complications such as myocardial infarction, stroke, or distal vessel occlusion.

The cardiovascular system is highly susceptible to embolic events. The heart and major blood vessels are intricately interconnected, making them vulnerable to embolization from various sources, including dislodged plaque, thrombi, or foreign material. Usage of embolic protection devices provides an added layer of safety by acting as a barrier and preventing embolic debris from reaching critical vessels or organs.

Development of advanced embolic protection devices specifically tailored for cardiovascular procedures has further reinforced their predominant use in this field. These devices are designed to be compatible with the anatomy and physiology of the cardiovascular system, providing optimal protection and ease of use during interventions.

Extensive research and clinical evidence supporting the efficacy and safety of embolic protection devices in cardiovascular procedures have contributed to their widespread adoption.

Access to Necessary Infrastructure and Resources Bolstering Hospitals & Clinics Segment

Based on end-user, the hospitals & clinics segment is projected to account for major share of the global market in the next few years.

Hospitals and clinics are equipped with specialized catheterization laboratories and operating rooms where various cardiovascular and neurovascular interventions are performed. Embolic protection devices are primarily used in these procedures; hence, hospitals & clinics naturally become the primary consumers of these devices.

Large number of patients undergoing interventional procedures for cardiovascular diseases, peripheral artery diseases, and other conditions in hospitals & clinics contributes to the substantial embolic protection devices market demand.

Hospitals and clinics tend to have comprehensive cardiac and vascular care departments, housing specialized healthcare professionals who are familiar with these devices.

Hospitals often have access to the necessary infrastructure and resources to procure and stock medical devices, including embolic protection devices. Hospitals establish relationships with manufacturers and distributors for a steady supply of these devices. The institutional purchasing power of hospitals & clinics allows them to negotiate favorable pricing and procurement contracts, further consolidating their position as major consumers in the market.

Regional Outlook

According to the latest embolic protection devices market forecast, North America is projected to account for major share of the global industry during the forecast period. The U.S. is the largest contributor to market revenue in the region.

Rise in incidence of cardiovascular & neurovascular diseases and presence of prominent manufacturers are contributing to embolic protection devices market growth in the region.

The embolic protection devices market size in Asia Pacific is projected to be propelled by high prevalence of CVDs and emergence of local companies. Multiple strategic initiatives implemented by innovative companies are anticipated to bolster market expansion in Asia Pacific in the near future.

Analysis of Key Players in Global Embolic Protection Devices Industry

The latest embolic protection devices market research report provides profiles of leading players operating in the global industry.

InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc., Edwards Lifesciences Corporation, and Lepu Medical Technology are the prominent players operating in the global market.

These players are focusing on merger & acquisition, strategic collaborations, and new product launches to expand presence and gain lucrative embolic protection devices industry share. Moreover, these players are following the embolic protection devices market trends to gain revenue benefits.

Key Developments in Global Embolic Protection Devices Market

  • In October 2020, Keystone Heart, Ltd., a Venus Medtech Company, completed its first worldwide commercial case using the TriGUARD 3 Cerebral Embolic Protection (CEP) Device. This device is designed and engineered with the aim of minimizing the risk of cerebral injury by redirecting embolic particles away from the brain.
  • In January 2022, Cardiovascular Systems, Inc. issued a recall for the WIRION Embolic Protection Device due to complaints of filter breakage during the retrieval process.

Each of these players has been profiled in the embolic protection devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Embolic Protection Devices Market Snapshot

Attribute Detail

Size in 2022

US$ 564.5 Mn

Forecast (Value) in 2031

More than US$ 1.1 Bn

Growth Rate (CAGR)

8.0%

Forecast Period

2023-2031

Historical Data Available for

2017-2022

Quantitative Units

US$ Mn/Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product
    • Distal Occlusion Devices
    • Proximal Occlusion Devices
    • Distal Filters
  • Application
    • Cardiovascular Diseases
    • Neurovascular Diseases
    • Peripheral Vascular Diseases
  • End-user
    • Hospitals & Clinics
    • Ambulatory Surgery Centers
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • InspireMD, Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Cardinal Health
  • Contego Medical, LLC
  • Silk Road Medical, Inc.
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global embolic protection devices market in 2022?

The global industry was valued at US$ 564.5 Mn in 2022

How big will be the embolic protection devices industry in 2031?

It is projected to reach more than US$ 1.1 Bn by 2031

How is the embolic protection devices business expected to grow during the forecast period?

It is expected to advance at a CAGR of 8.0% from 2023 to 2031

Which was the leading product segment of embolic protection devices?

The distal filters product segment accounted for the largest share in 2022

Which region is more lucrative for embolic protection devices vendors?

North America is the more lucrative region

Who are the prominent embolic protection device manufacturers?

InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc., Edwards Lifesciences Corporation, and Lepu Medical Technology are the prominent players in the market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Embolic Protection Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Embolic Protection Devices Market Analysis and Forecast, 2020-2031

5. Key Insights

    5.1. Technological Advancements

    5.2. Disease Prevalence & Incidence Rate Globally With Key Countries

    5.3. Regulatory Scenario by Region/Globally

    5.4. COVID-19 Impact Analysis

6. Global Embolic Protection Devices Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product, 2020-2031

        6.3.1. Distal Occlusion Devices

        6.3.2. Proximal Occlusion Devices

        6.3.3. Distal Filters

    6.4. Market Attractiveness Analysis, by Product

7. Global Embolic Protection Devices Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Application, 2020-2031

        7.3.1. Cardiovascular Diseases

        7.3.2. Neurovascular Diseases

        7.3.3. Peripheral Vascular Diseases

    7.4. Market Attractiveness Analysis, by Application

8. Global Embolic Protection Devices Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2020-2031

        8.3.1. Hospitals & Clinics

        8.3.2. Ambulatory Surgery Centers

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Embolic Protection Devices Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2020-2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America (LATAM)

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Embolic Protection Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2020-2031

        10.2.1. Distal Occlusion Devices

        10.2.2. Proximal Occlusion Devices

        10.2.3. Distal Filters

    10.3. Market Value Forecast, by Application, 2020-2031

        10.3.1. Cardiovascular Diseases

        10.3.2. Neurovascular Diseases

        10.3.3. Peripheral Vascular Diseases

    10.4. Market Value Forecast, by End-user, 2020-2031

        10.4.1. Hospitals & Clinics

        10.4.2. Ambulatory Surgery Centers

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2020-2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Embolic Protection Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2020-2031

        11.2.1. Distal Occlusion Devices

        11.2.2. Proximal Occlusion Devices

        11.2.3. Distal Filters

    11.3. Market Value Forecast, by Application, 2020-2031

        11.3.1. Cardiovascular Diseases

        11.3.2. Neurovascular Diseases

        11.3.3. Peripheral Vascular Diseases

    11.4. Market Value Forecast, by End-user, 2020-2031

        11.4.1. Hospitals & Clinics

        11.4.2. Ambulatory Surgery Centers

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2020-2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Embolic Protection Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2020-2031

        12.2.1. Distal Occlusion Devices

        12.2.2. Proximal Occlusion Devices

        12.2.3. Distal Filters

    12.3. Market Value Forecast, by Application, 2020-2031

        12.3.1. Cardiovascular Diseases

        12.3.2. Neurovascular Diseases

        12.3.3. Peripheral Vascular Diseases

    12.4. Market Value Forecast, by End-user, 2020-2031

        12.4.1. Hospitals & Clinics

        12.4.2. Ambulatory Surgery Centers

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2020-2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America (LATAM) Embolic Protection Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2020-2031

        13.2.1. Distal Occlusion Devices

        13.2.2. Proximal Occlusion Devices

        13.2.3. Distal Filters

    13.3. Market Value Forecast, by Application, 2020-2031

        13.3.1. Cardiovascular Diseases

        13.3.2. Neurovascular Diseases

        13.3.3. Peripheral Vascular Diseases

    13.4. Market Value Forecast, by End-user, 2020-2031

        13.4.1. Hospitals & Clinics

        13.4.2. Ambulatory Surgery Centers

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2020-2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of LATAM

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Embolic Protection Devices Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2020-2031

        14.2.1. Distal Occlusion Devices

        14.2.2. Proximal Occlusion Devices

        14.2.3. Distal Filters

    14.3. Market Value Forecast, by Application, 2020-2031

        14.3.1. Cardiovascular Diseases

        14.3.2. Neurovascular Diseases

        14.3.3. Peripheral Vascular Diseases

    14.4. Market Value Forecast, by End-user, 2020-2031

        14.4.1. Hospitals & Clinics

        14.4.2. Ambulatory Surgery Centers

        14.4.3. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2020-2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of MEA

    14.6. Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. InspireMD, Inc.

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Boston Scientific Corporation

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Abbott Laboratories

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Medtronic plc

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Cardinal Health

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Contego Medical, LLC

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. Silk Road Medical, Inc.

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. Edwards Lifesciences Corporation

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Lepu Medical Technology

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

List of Tables

Table 01: Global Embolic Protection Devices Market Size (US$ Mn) Forecast, by Product, 2020-2031

Table 02: Global Embolic Protection Devices Market Size (US$ Mn) Forecast, by Application, 2020-2031

Table 03: Global Embolic Protection Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2031

Table 04: Global Embolic Protection Devices Market Size (US$ Mn) Forecast, by Region, 2020-2031

Table 05: North America Embolic Protection Devices Market Size (US$ Mn) Forecast, by Country, 2020-2031

Table 06: North America Embolic Protection Devices Market Size (US$ Mn) Forecast, by Product, 2020-2031

Table 07: North America Embolic Protection Devices Market Size (US$ Mn) Forecast, by Application, 2020-2031

Table 08: North America Embolic Protection Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2031

Table 09: Europe Embolic Protection Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031

Table 10: Europe Embolic Protection Devices Market Size (US$ Mn) Forecast, by Product, 2020-2031

Table 11: Europe Embolic Protection Devices Market Size (US$ Mn) Forecast, by Application, 2020-2031

Table 12: Europe Embolic Protection Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2031

Table 13: Asia Pacific Embolic Protection Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031

Table 14: Asia Pacific Embolic Protection Devices Market Size (US$ Mn) Forecast, by Product, 2020-2031

Table 15: Asia Pacific Embolic Protection Devices Market Size (US$ Mn) Forecast, by Application, 2020-2031

Table 16: Asia Pacific Embolic Protection Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2031

Table 17: Latin America Embolic Protection Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031

Table 18: Latin America Embolic Protection Devices Market Size (US$ Mn) Forecast, by Product, 2020-2031

Table 19: Latin America Embolic Protection Devices Market Size (US$ Mn) Forecast, by Application, 2020-2031

Table 20: Latin America Embolic Protection Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2031

Table 21: Middle East & Africa Embolic Protection Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031

Table 22: Middle East & Africa Embolic Protection Devices Market Size (US$ Mn) Forecast, by Product, 2020-2031

Table 23: Middle East & Africa Embolic Protection Devices Market Size (US$ Mn) Forecast, by Application, 2020-2031

Table 24: Middle East & Africa Embolic Protection Devices Market Size (US$ Mn) Forecast, by End-user, 2020-2031

List of Figures

Figure 01: Global Embolic Protection Devices Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031

Figure 02: Global Embolic Protection Devices Market Revenue (US$ Mn), by Product, 2021

Figure 03: Global Embolic Protection Devices Market Value Share, by Product, 2021

Figure 04: Global Embolic Protection Devices Market Revenue (US$ Mn), by Application, 2021

Figure 05: Global Embolic Protection Devices Market Value Share, by Application, 2021

Figure 06: Global Embolic Protection Devices Market Revenue (US$ Mn), by End-user, 2021

Figure 07: Global Embolic Protection Devices Market Value Share, by End-user, 2021

Figure 08: Global Embolic Protection Devices Market Value Share, by Region, 2021

Figure 09: Global Embolic Protection Devices Market Value (US$ Mn) Forecast, 2020-2031

Figure 10: Global Embolic Protection Devices Market Value Share Analysis, by Product, 2021 and 2031

Figure 11: Global Embolic Protection Devices Market Attractiveness Analysis, by Product, 2022-2031

Figure 12: Global Embolic Protection Devices Market Value Share Analysis, by Application, 2021 and 2031

Figure 13: Global Embolic Protection Devices Market Attractiveness Analysis, by Application, 2022-2031

Figure 14: Global Embolic Protection Devices Market Value Share Analysis, by End-user, 2021 and 2031

Figure 15: Global Embolic Protection Devices Market Attractiveness Analysis, by End-user, 2022-2031

Figure 16: Global Embolic Protection Devices Market Value Share Analysis, by Region, 2021 and 2031

Figure 17: Global Embolic Protection Devices Market Attractiveness Analysis, by Region, 2022-2031

Figure 18: North America Embolic Protection Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031

Figure 19: North America Embolic Protection Devices Market Attractiveness Analysis, by Country, 2020-2031

Figure 20: North America Embolic Protection Devices Market Value Share Analysis, by Country, 2021 and 2031

Figure 21: North America Embolic Protection Devices Market Value Share Analysis, by Product, 2021 and 2031

Figure 22: North America Embolic Protection Devices Market Value Share Analysis, by Application, 2021 and 2031

Figure 23: North America Embolic Protection Devices Market Value Share Analysis, by End-user, 2021 and 2031

Figure 24: North America Embolic Protection Devices Market Attractiveness Analysis, by Product, 2022-2031

Figure 25: North America Embolic Protection Devices Market Attractiveness Analysis, by Application, 2022-2031

Figure 26: North America Embolic Protection Devices Market Attractiveness Analysis, by End-user, 2022-2031

Figure 27: Europe Embolic Protection Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031

Figure 28: Europe Embolic Protection Devices Market Attractiveness Analysis, by Country/Sub-region, 2020-2031

Figure 29: Europe Embolic Protection Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 30: Europe Embolic Protection Devices Market Value Share Analysis, by Product, 2021 and 2031

Figure 31: Europe Embolic Protection Devices Market Value Share Analysis, by Application, 2021 and 2031

Figure 32: Europe Embolic Protection Devices Market Value Share Analysis, by End-user, 2021 and 2031

Figure 33: Europe Embolic Protection Devices Market Attractiveness Analysis, by Product, 2022-2031

Figure 34: Europe Embolic Protection Devices Market Attractiveness Analysis, by Application, 2022-2031

Figure 35: Europe Embolic Protection Devices Market Attractiveness Analysis, by End-user, 2022-2031

Figure 36: Asia Pacific Embolic Protection Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031

Figure 37: Asia Pacific Embolic Protection Devices Market Attractiveness Analysis, by Country/Sub-region, 2020-2031

Figure 38: Asia Pacific Embolic Protection Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 39: Asia Pacific Embolic Protection Devices Market Value Share Analysis, by Product, 2021 and 2031

Figure 40: Asia Pacific Embolic Protection Devices Market Value Share Analysis, by Application, 2021 and 2031

Figure 41: Asia Pacific Embolic Protection Devices Market Value Share Analysis, by End-user, 2021 and 2031

Figure 42: Asia Pacific Embolic Protection Devices Market Attractiveness Analysis, by Product, 2022-2031

Figure 43: Asia Pacific Embolic Protection Devices Market Attractiveness Analysis, by Application, 2022-2031

Figure 44: Asia Pacific Embolic Protection Devices Market Attractiveness Analysis, by End-user, 2022-2031

Figure 45: Latin America Embolic Protection Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031

Figure 46: Latin America Embolic Protection Devices Market Attractiveness Analysis, by Country/Sub-region, 2020-2031

Figure 47: Latin America Embolic Protection Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 48: Latin America Embolic Protection Devices Market Value Share Analysis, by Product, 2021 and 2031

Figure 49: Latin America Embolic Protection Devices Market Value Share Analysis, by Application, 2021 and 2031

Figure 50: Latin America Embolic Protection Devices Market Value Share Analysis, by End-user, 2021 and 2031

Figure 51: Latin America Embolic Protection Devices Market Attractiveness Analysis, by Product, 2022-2031

Figure 52: Latin America Embolic Protection Devices Market Attractiveness Analysis, by Application, 2022-2031

Figure 53: Latin America Embolic Protection Devices Market Attractiveness Analysis, by End-user, 2022-2031

Figure 54: Middle East & Africa Embolic Protection Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031

Figure 55: Middle East & Africa Embolic Protection Devices Market Attractiveness Analysis, by Country/Sub-region, 2020-2031

Figure 56: Middle East & Africa Embolic Protection Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 57: Middle East & Africa Embolic Protection Devices Market Value Share Analysis, by Product, 2021 and 2031

Figure 58: Middle East & Africa Embolic Protection Devices Market Value Share Analysis, by Application, 2021 and 2031

Figure 59: Middle East & Africa Embolic Protection Devices Market Value Share Analysis, by End-user, 2021 and 2031

Figure 60: Middle East & Africa Embolic Protection Devices Market Attractiveness Analysis, by Product, 2022-2031

Figure 61: Middle East & Africa Embolic Protection Devices Market Attractiveness Analysis, by Application, 2022-2031

Figure 62: Middle East & Africa Embolic Protection Devices Market Attractiveness Analysis, by End-user, 2022-2031

Copyright © Transparency Market Research, Inc. All Rights reserved